LCM
ATOS icon

Laurion Capital Management’s Atossa Therapeutics ATOS Stock Holding History

Laurion Capital Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-148,387
Closed -$4.01M – 570
2024
Q1 		$4.01M Hold
148,387
– – 0.11% 279
2023
Q4 		$1.96M Hold
148,387
– – 0.07% 298
2023
Q3 		$1.64M Hold
148,387
– – 0.04% 346
2023
Q2 		$2.8M Hold
148,387
– – 0.12% 295
2023
Q1 		$1.61M Hold
148,387
– – 0.07% 282
2022
Q4 		$1.18M Hold
148,387
– – 0.03% 322
2022
Q3 		$1.85M Hold
148,387
– – 0.05% 332
2022
Q2 		$2.43M Buy
+148,387
New +$2.34M 0.1% 216

Other funds holding ATOS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return